BMY
Bristol-Myers Squibb·NYSE
--
--(--)
--
--(--)
6.60 / 10
Outperform
Technical analysis reveals a score of 6.6/10: bullish Marubozu White and MACD Death Cross signals outweigh the bearish MACD Golden Cross, indicating cautious optimism for near-term price action.
Analysis Checks(2/3)
MACD Death Cross
Score8.39/10
Win Rate86.67%
Hist. Signals15
Avg Return1.77%
Score8.39/10
Win Rate86.67%
Hist. Signals15
Avg Return1.77%
Marubozu White
Score7.47/10
Win Rate80.00%
Hist. Signals5
Avg Return0.60%
Score7.47/10
Win Rate80.00%
Hist. Signals5
Avg Return0.60%
MACD Golden Cross
Score3.93/10
Win Rate53.85%
Hist. Signals13
Avg Return-0.43%
Score3.93/10
Win Rate53.85%
Hist. Signals13
Avg Return-0.43%
MACD Death Cross
Score8.39/10
Win Rate86.67%
Hist. Signals15
Avg Return1.77%
Score8.39/10
Win Rate86.67%
Hist. Signals15
Avg Return1.77%
MACD Golden Cross
Score3.93/10
Win Rate53.85%
Hist. Signals13
Avg Return-0.43%
Score3.93/10
Win Rate53.85%
Hist. Signals13
Avg Return-0.43%
Marubozu White
Score7.47/10
Win Rate80.00%
Hist. Signals5
Avg Return0.60%
Score7.47/10
Win Rate80.00%
Hist. Signals5
Avg Return0.60%
Technical Analysis of BMY?
- BMY presents a Outperform setup with a Technical Score of 6.60/10. Key technical indicators highlight an RSI of 77.61 and a MACD of 1.00, with the trend anchored by the 50-Day SMA at 54.01. Traders should monitor key support at 58.16 and resistance at 60.72.
